Paper41345178
In-silico investigations of bioactive compounds from ginger against Lassa fever virus nucleoprotein.
Eyo AE and 12 others. Sci Rep, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. In-silico investigations of bioactive compounds from ginger against Lassa fever virus nucleoprotein. Papers, record 41345178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41345178
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In-silico investigations of bioactive compounds from ginger against Lassa fever virus nucleoprotein.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Zingiber officinale | Major topic |
| Nucleoproteins | Major topic |
| Antiviral Agents | Major topic |
| Lassa virus | Major topic |
| Viral Proteins | Major topic |
| Molecular Docking Simulation | |
| Molecular Dynamics Simulation | |
| Catechols | |
| Fatty Alcohols | |
| Ligands |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| (NRF2021_SETI_HSW_00478) | 2021 Tertiary Education Trust Fund (TetFund) National Research Fund (NRF) | PubMed |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37497547 | Development of a new drug candidate for the inhibition of Lassa virus glycoprotein and nucleoprotein by modification of evodiamine as promising therapeutic agents. | Front Microbiol | 2023 | https://conductscience.org/library/papers/37497547 | PubMed |
| 2 | 23202452 | Pathogenesis of Lassa fever. | Viruses | 2012 | https://conductscience.org/library/papers/23202452 | PubMed |
| 3 | 34108251 | A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains. | Sci Transl Med | 2021 | https://conductscience.org/library/papers/34108251 | PubMed |
| 4 | 10592235 | The Protein Data Bank. | Nucleic Acids Res | 2000 | https://conductscience.org/library/papers/10592235 | PubMed |
| 5 | 35163692 | Molecular Docking and Molecular Dynamics Simulations Discover Curcumin Analogue as a Plausible Dual Inhibitor for SARS-CoV-2. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163692 | PubMed |
| 6 | 34954327 | Applications of density functional theory in COVID-19 drug modeling. | Drug Discov Today | 2022 | https://conductscience.org/library/papers/34954327 | PubMed |
| 7 | 23842804 | Allosite: a method for predicting allosteric sites. | Bioinformatics | 2013 | https://conductscience.org/library/papers/23842804 | PubMed |
| 8 | 38400041 | The Importance of Lassa Fever and Its Disease Management in West Africa. | Viruses | 2024 | https://conductscience.org/library/papers/38400041 | PubMed |
| 9 | 34458236 | In Silico Pharmacokinetics, ADMET Study and Conceptual DFT Analysis of Two Plant Cyclopeptides Isolated From Rosaceae as a Computational Peptidology Approach. | Front Chem | 2021 | https://conductscience.org/library/papers/34458236 | PubMed |
| 10 | 39259072 | The efficacy and safety of ginger (Zingiber officinale) rhizome extract in outpatients with COVID-19: A randomized double-blind placebo-control clinical trial. | Medicine (Baltimore) | 2024 | https://conductscience.org/library/papers/39259072 | PubMed |
| 11 | 32420412 | Anti-viral activity of Zingiber officinale (Ginger) ingredients against the Chikungunya virus. | Virusdisease | 2020 | https://conductscience.org/library/papers/32420412 | PubMed |
| 12 | 19833188 | Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol. | J Ethnopharmacol | 2010 | https://conductscience.org/library/papers/19833188 | PubMed |
| 13 | 23123794 | Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. | J Ethnopharmacol | 2013 | https://conductscience.org/library/papers/23123794 | PubMed |
| 14 | 29182532 | Human Skin Permeation Studies with PPARγ Agonist to Improve Its Permeability and Efficacy in Inflammatory Processes. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/29182532 | PubMed |
| 15 | 38369392 | Lassa fever vaccine use cases and demand: Perspectives from select West African experts. | Vaccine | 2024 | https://conductscience.org/library/papers/38369392 | PubMed |
| 16 | 36298533 | Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/36298533 | PubMed |
| 17 | 40835743 | In-silico screening of small compounds against Lassa fever haemorrhagic virus nucleoprotein. | Sci Rep | 2025 | https://conductscience.org/library/papers/40835743 | PubMed |
| 18 | 34094756 | Management of Lassa Fever: A Current Update. | Cureus | 2021 | https://conductscience.org/library/papers/34094756 | PubMed |
| 19 | 38001868 | Ginger Bioactives: A Comprehensive Review of Health Benefits and Potential Food Applications. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/38001868 | PubMed |
| 20 | 36747234 | Antimicrobial analysis of honey against Staphylococcus aureus isolates from wound, ADMET properties of its bioactive compounds and in-silico evaluation against dihydropteroate synthase. | BMC Complement Med Ther | 2023 | https://conductscience.org/library/papers/36747234 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41345178
GET https://conductscience.org/api/papers/v1/41345178/references?page=2